Europe — EMA
Orebriton (Ticagrelor)
Ticagrelor, the active ingredient in Orebriton, is an antiplatelet medication presented as a tablet for oral use. It reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome and…
Request sourcing
1
Pack/s
What is Ticagrelor?
Ticagrelor, the active ingredient in Orebriton, is an antiplatelet medication presented as a tablet for oral use. It reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome and those undergoing .
GNH USA supplies Orebriton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Ticagrelor used for?
Orebriton acts ... .... … .... .... ... .... ... .... ... .... ... ... """ " """ ...
Product details
Drug
Ticagrelor
Route
Oral Use
Manufacturer
Zentiva, K.S.
Origin
EU
Related products

BRILINTA 60 mg/1
Ticagrelor · 60 mg
Brilinta
TABLET
AstraZeneca Pharmaceuticals LP
USA

BRILINTA 90 mg/1
Ticagrelor · 90 mg
Brilinta
TABLET
AstraZeneca Pharmaceuticals LP
USA

BRILINTA 90 mg/1
Ticagrelor · 90 mg
Brilinta
TABLET
AstraZeneca Pharmaceuticals LP
USA

BRILINTA 90 mg/1
Ticagrelor · 90 mg
Brilinta
TABLET
AstraZeneca Pharmaceuticals LP
USA